GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProKidney Corp (MEX:PROK) » Definitions » Total Liabilities

ProKidney (MEX:PROK) Total Liabilities : MXN410.39 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is ProKidney Total Liabilities?

ProKidney's Total Liabilities for the quarter that ended in Mar. 2024 was MXN410.39 Mil.

ProKidney's quarterly Total Liabilities increased from Sep. 2023 (MXN411.40 Mil) to Dec. 2023 (MXN495.92 Mil) but then declined from Dec. 2023 (MXN495.92 Mil) to Mar. 2024 (MXN410.39 Mil).

ProKidney's annual Total Liabilities declined from Dec. 2021 (MXN274.50 Mil) to Dec. 2022 (MXN254.56 Mil) but then increased from Dec. 2022 (MXN254.56 Mil) to Dec. 2023 (MXN495.92 Mil).


ProKidney Total Liabilities Historical Data

The historical data trend for ProKidney's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProKidney Total Liabilities Chart

ProKidney Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Liabilities
135.98 274.50 254.56 495.92

ProKidney Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 255.47 467.63 411.40 495.92 410.39

ProKidney Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

ProKidney's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=425.001+(61.277+9.642
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=495.92

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=7138.554-6642.634
=495.92

ProKidney's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=320.324+(80.641+9.427
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=410.39

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=6435.414-6025.021
=410.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ProKidney Total Liabilities Related Terms

Thank you for viewing the detailed overview of ProKidney's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


ProKidney (MEX:PROK) Business Description

Traded in Other Exchanges
Address
2000 Frontis Plaza Boulevard, Suite 250, Winston-Salem, NC, USA, 27103
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.